Cited by 148Inhalation and Respiratory Drug DeliveryNanoparticle-Based Drug DeliveryAdvanced Drug Delivery Systems

The DOI matches its Crossref record; 115 of the 117 references it cites were found in a registry or an index.

Therapeutic Liposomal Dry Powder Inhalation Aerosols for Targeted Lung Delivery

Willis, Lauren, Hayes, Don, Mansour, Heidi M.·2012·Lung

Open this paper in CoChat — free account

Abstract

Therapeutic liposomal powders (i.e., lipospheres and proliposomes) for dry powder inhalation aerosol delivery, formulated with phospholipids similar to endogenous lung surfactant, offer unique opportunities in pulmonary nanomedicine while offering controlled release and enhanced stability. Many pulmonary diseases such as lung cancer, tuberculosis (TB), cystic fibrosis (CF), bacterial and fungal lung infections, asthma, and chronic obstructive pulmonary disease (COPD) could greatly benefit from this type of pulmonary nanomedicine approach that can be delivered in a targeted manner by dry powder inhalers (DPIs). These delivery systems may require smaller doses for efficacy, exhibit reduced toxicity, fewer side effects, controlled drug release over a prolonged time period, and increased formulation stability as inhaled powders. This state-of-the-art review presents these novel aspects in depth.

Integrity signals

Registry

Crossref · 10.1007/s00408-011-9360-x

Cites

115 of 115 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Inhaling medicines: delivering drugs to the body through the lungs
Patton, J. S., & Byron, P. R. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2153 · Cited by 1,370
Deaths: final data for 2007.
Xu, J., Kochanek, K. D., Murphy, S. L., & Tejada‐Vera, B. (2010) · PubMed · Cited by 650
The Lungs as a Portal of Entry for Systemic Drug Delivery
Patton, J. S., Fishburn, C. S., & Weers, J. G. (2004) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200409-049ta · Cited by 564
Nanomedicine in pulmonary delivery
Mansour, H. M., Haemosu, & Wu, X. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s4937 · Cited by 497
Self-citation
Drug information handbook
OGILVIE, R. I. (1983) · PubMed Central · Cited by 395
Nanoparticle formulations in pulmonary drug delivery
Bailey, M. M., & Berkland, C. J. (2009) · Medicinal Research Reviews · doi:10.1002/med.20140 · Cited by 302
Aerosolized Liposomal Amphotericin B for the Prevention of Invasive Pulmonary Aspergillosis during Prolonged Neutropenia: A Randomized, Placebo‐Controlled Trial
Rijnders, B. J. A., Cornelissen, J. J., Slobbe, L., Becker, M. J., Doorduijn, J. K., Hop, W. C. J., Ruijgrok, E. J., Löwenberg, B., Vulto, A. G., Lugtenburg, P. J., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/586739 · Cited by 284
A Fullerene−Paclitaxel Chemotherapeutic: Synthesis, Characterization, and Study of Biological Activity in Tissue Culture
Zakharian, T. Y., Seryshev, A. B., Sitharaman, B., Gilbert, B. E., Knight, V., & Wilson, L. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0546525 · Cited by 277
Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: A European consensus
Heijerman, H. G. M., Westerman, E. M., Conway, S., & Touw, D. J. (2009) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2009.04.005 · Cited by 264
Nanomedicine for respiratory diseases
Pison, U., Welte, T., Giersig, M., & Groneberg, D. A. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.068 · Cited by 262
Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages
Vyas, S. P., Kannan, M., Jain, S., Mishra, V. K., & Singh, P. (2003) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.08.017 · Cited by 262
Formulation and Pharmacokinetics of Self-Assembled Rifampicin Nanoparticle Systems for Pulmonary Delivery
Sung, J. C., Padilla, D. J., Garcia‐Contreras, L., VerBerkmoes, J. L., Durbin, D., Peloquin, C. A., Elbert, K. J., Hickey, A. J., & Edwards, D. A. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9894-2 · Cited by 247
Modified-Release Drug Delivery Technology
Rathbone, M. J., Hadgraft, J., & Roberts, M. S. (2007) · Medical Entomology and Zoology · Cited by 245
Investigation of the proinflammatory potential of biodegradable nanoparticle drug delivery systems in the lung
Dailey, L. A., Jekel, N., Fink, L., Gessler, T., Schmehl, T., Wittmar, M., Kissel, T., & Seeger, W. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.01.016 · Cited by 220
Formation, characterization, and fate of inhaled drug nanoparticles
Zhang, J., Wu, L., Chan, H., & Watanabe, W. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.11.002 · Cited by 213
Clinical Evaluation of the Delivery and Safety of Aerosolized Liposomal 9-Nitro-20(S)-Camptothecin in Patients with Advanced Pulmonary Malignancies
Verschraegen, C. F., Gilbert, B. E., Loyer, E. M., Huaringa, A. J., Walsh, G., Newman, R. A., & Knight, V. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0929-3 · Cited by 183
Inhalable microparticles containing large payload of anti-tuberculosis drugs
Muttil, P., Kaur, J. P., Kumar, K., Yadav, A. B., Sharma, R., & Misra, A. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.06.006 · Cited by 173
Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles
Azarmi, S., TAO, X., Chen, H., Wang, Z., FINLAY, W., Löbenberg, R., & Roa, W. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.03.052 · Cited by 169
Phase I Study of Aerosolized SLIT Cisplatin in the Treatment of Patients with Carcinoma of the Lung
Wittgen, B. P. H., Kunst, P. W. A., van der Born, K., van Wijk, A. W., Perkins, W. R., Pilkiewicz, F. G., Perez-Soler, R., Nicholson, S., Peters, G. J., & Postmus, P. E. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1480 · Cited by 166
Liposomes as drug carriers in cancer chemotherapy
Weinstein, J. N., & Leserman, L. (1984) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(84)90035-4 · Cited by 158
Paclitaxel liposome aerosol treatment induces inhibition of pulmonary metastases in murine renal carcinoma model.
Koshkina, N. V., Waldrep, J. C., Roberts, L., Golunski, E., Melton, S., & Knight, V. (2001) · PubMed · Cited by 154
Relating the phagocytosis of microparticles by alveolar macrophages to surface chemistry: the effect of 1,2-dipalmitoylphosphatidylcholine
Évora, C., Soriano, I., Rogers, R. A., Shakesheff, K. M., Hanes, J. S., & Langer, R. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00149-1 · Cited by 147
Aerosolized Chemotherapy
Gagnadoux, F., Hureaux, J., Vecellio, L., Urban, T., Pape, A. L., Valo, I., Montharu, J., Leblond, V., Boisdron‐Celle, M., Lerondel, S., et al. (2008) · Journal of Aerosol Medicine · doi:10.1089/jamp.2007.0656 · Cited by 144
Immunosuppressive therapy after human lung transplantation
Knoop, C., Haverich, A., & Fischer, S. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00039203 · Cited by 125
Micro- and nanocarrier-mediated lung targeting
Kurmi, B. D., Kayat, J., Gajbhiye, V., Tekade, R. K., & Jain, N. K. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2010.492212 · Cited by 122
Physicochemical Characterization and Stability of Rifampicin Liposome Dry Powder Formulations for Inhalation
Changsan, N., Chan, H., Separovic, F., & Srichana, T. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21441 · Cited by 108
Phase I/II Study of Inhaled Doxorubicin Combined with Platinum-Based Therapy for Advanced Non–Small Cell Lung Cancer
Otterson, G. A., Villalona-Calero, M. A., Hicks, W. J., Pan, X. J., Ellerton, J. A., Gettinger, S. N., & Murren, J. R. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3015 · Cited by 108
Co-spray-dried mannitol–ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease
Adi, H., Young, P. M., Chan, H., Agus, H., & Traini, D. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.03.020 · Cited by 107
Prophylactic efficacy of aerosolized liposomal (AmBisome) and non-lipsomal (Fungizone) amphotericin B in murine pulmonary aspergillosis
Allen, S. D., Sorensen, K. N., Neial, M. J., Durrant, C., & Proffitt, R. T. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/34.6.1001 · Cited by 105
Pulmonary distribution and clearance of two beclomethasone liposome formulations in healthy volunteers
Saari, M., Vidgren, M. T., Koskinen, M. O., Turjanmaa, V., & Nieminen, M. M. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00398-6 · Cited by 105
Development of Spray Dried Liposomal Dry Powder Inhaler of Dapsone
Chougule, M. B., Padhi, B. K., & Misra, A. R. (2008) · AAPS PharmSciTech · doi:10.1208/s12249-007-9024-6 · Cited by 104
Pharmacokinetic and Pharmacodynamic Evaluation of Liposomal Amikacin for Inhalation in Cystic Fibrosis Patients with Chronic Pseudomonal Infection
Okusanya, Ó. O., Bhavnani, S. M., Hammel, J., Minic, P. B., Dupont, L., Forrest, A., Mulder, G.-J., Mackinson, C., Ambrose, P. G., & Gupta, R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00872-08 · Cited by 104
Recent advances in liposomal dry powder formulations: preparation and evaluation
Misra, A. R., Jinturkar, K., Patel, D. H., Lalani, J., & Chougule, M. B. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240802652309 · Cited by 103
No lung toxicity after repeated aerosol or intravenous delivery of plasmid-cationic liposome complexes
Canonico, A. E., Plitman, J. D., Conary, J. T., Meyrick, B. O., & Brigham, K. L. (1994) · Journal of Applied Physiology · doi:10.1152/jappl.1994.77.1.415 · Cited by 103
Anticancer exffect of 9-nitrocamptothecin liposome aerosol on human cancer xenografts in nude mice
Knight, V., Koshkina, N. V., Waldrep, J. C., Giovanella, B. C., & Gilbert, B. E. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050965 · Cited by 102
9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice.
Koshkina, N. V., Kleinerman, E. S., Waidrep, C., Jia, S.-F., Worth, L. L., Gilbert, B. E., & Knight, V. (2000) · PubMed · Cited by 101
Aerosolized liposome-based delivery of amphotericin B to alveolar macrophages
Vyas, S. P., QURAISHI, S., Gupta, S., & Jaganathan, K. S. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.02.003 · Cited by 100
A Gamma Scintigraphy Study to Investigate Lung Deposition and Clearance of Inhaled Amikacin-Loaded Liposomes in Healthy Male Volunteers
Weers, J. G., Metzheiser, B., Taylor, G., Warren, S., Meers, P. R., & Perkins, W. R. (2009) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2008.0693 · Cited by 98
Nano-liposomal dry powder inhaler of tacrolimus: preparation, characterization, and pulmonary pharmacokinetics.
Chougule, M. B., Padhi, B. K., & Misra, A. R. (2007) · PubMed Central · Cited by 97
Lectin-functionalized liposomes for pulmonary drug delivery: effect of nebulization on stability and bioadhesion
Abu‐Dahab, R., Schäfer, U. F., & Lehr, C. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00147-6 · Cited by 95
Budesonide Nanoparticle Agglomerates as Dry Powder Aerosols With Rapid Dissolution
El-Gendy, N. A., Gorman, E. M., Munson, E. J., & Berkland, C. J. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21630 · Cited by 90
Liposomal dry powders as aerosols for pulmonary delivery of proteins
Lu, D., & Hickey, A. J. (2005) · AAPS PharmSciTech · doi:10.1208/pt060480 · Cited by 85
Phospholipid dry powders produced by spray drying processing: structural, thermodynamic and physical properties
Alves, G. P., & Santana, M. H. A. (2004) · Powder Technology · doi:10.1016/j.powtec.2004.06.008 · Cited by 84
Acute Effects of Liposome Aerosol Inhalation on Pulmonary Function in Healthy Human Volunteers
Thomas, D. A., Myers, M. A., Wichert, B. M., Schreier, H., & Gonzalez‐Rothi, R. J. (1991) · CHEST Journal · doi:10.1378/chest.99.5.1268 · Cited by 83
Regional Lung Deposition and Clearance of 99mTc-Labeled Beclomethasone-DLPC Liposomes in Mild and Severe Asthma
Saari, S. M., Vidgren, M. T., Koskinen, M. O., Turjanmaa, V., Waldrep, J. C., & Nieminen, M. M. (1998) · CHEST Journal · doi:10.1378/chest.113.6.1573 · Cited by 82
Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study
Lowry, C. M., Marty, F. M., Vargas, S. O., Lee, J. T., Fiumara, K., Deykin, A., & Baden, L. R. (2007) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2007.00209.x · Cited by 82
In vitro evaluation of inhalable isoniazid‐loaded surfactant liposomes as an adjunct therapy in pulmonary tuberculosis
Chimote, G., & Banerjee, R. (2010) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.31608 · Cited by 75
Lung Deposition of a Liposomal Cyclosporine A Inhalation Solution in Patients after Lung Transplantation
Behr, J., Zimmermann, G., Baumgartner, R., Leuchte, H. H., Neurohr, C., Brand, P., Herpich, C., Sommerer, K., Seitz, J., Menges, G., et al. (2009) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2008.0714 · Cited by 74
Enhanced Anti-Inflammation of Inhaled Dexamethasone Palmitate Using Mannosylated Liposomes in an Endotoxin-Induced Lung Inflammation Model
Wijagkanalan, W., Higuchi, Y., Kawakami, S., Teshima, M., Sasaki, H., & Hashida, M. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.050153 · Cited by 74
Rifampicin-loaded liposomes for the passive targeting to alveolar macrophages:in vitroandin vivoevaluation
Zaru, M., Sinico, C., Logu, A. D., Caddeo, C., Lai, F., Manca, M. L., & Fadda, A. M. (2009) · Journal of Liposome Research · doi:10.1080/08982100802610835 · Cited by 73
Dry powder inhalation of liposomal Ketotifen fumarate: formulation and characterization
Joshi, M., & Misra, A. R. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00705-0 · Cited by 72
Pulmonary Effects of Chronic Exposure to Liposome Aerosols in Mice
Myers, M. A., Thomas, D. A., Straub, L., Soucy, D. W., Niven, R. W., Kaltenbach, M. L., Hood, C. I., Schreier, H., & Gonzalez‐Rothi, R. J. (1993) · Experimental Lung Research · doi:10.3109/01902149309071077 · Cited by 72
Preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery
Kalantarian, P. (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s12415 · Cited by 70
Biological evaluation of pyrazinamide liposomes for treatment of Mycobacterium tuberculosis
El-Ridy, M. S., Mostafa, D. M., Shehab, A., Nasr, E. A. A., & El-Alim, S. H. A. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.09.017 · Cited by 70
Evaluation in vitro and in vivo of cationic liposome-expression construct complexes for cystic fibrosis gene therapy.
McLachlan, G., Davidson, D. J., Stevenson, B. J., Dickinson, P., Davidson‐Smith, H., Dorin, J. R., & Porteous, D. J. (1995) · PubMed · Cited by 68
Selective enhancement of pentamidine uptake in the lung by aerosolization and delivery in liposomes.
Debs, R. J., Straubinger, R. M., Brunette, E. N., Lin, J. M., Lin, E. J., Montgomery, A., Friend, D. S., & Papahadjopoulos, D. (1987) · PubMed · doi:10.1164/arrd.1987.135.3.731 · Cited by 68
Powder properties and their influence on dry powder inhaler delivery of an antitubercular drug
Sethuraman, V. V., & Hickey, A. J. (2002) · AAPS PharmSciTech · doi:10.1208/pt030428 · Cited by 68
A Receptor-targeted Nanocomplex Vector System Optimized for Respiratory Gene Transfer
Tagalakis, A. D., McAnulty, R. J., Devaney, J., Bottoms, S. E., Wong, J. B., Elbs, M., Writer, M. J., Hailes, H. C., Tabor, A. B., O’Callaghan, C., et al. (2008) · Molecular Therapy · doi:10.1038/mt.2008.38 · Cited by 66
Relationships between Equilibrium Spreading Pressure and Phase Equilibria of Phospholipid Bilayers and Monolayers at the Air−Water Interface
Mansour, H. M., & Zografi, G. (2007) · Langmuir · doi:10.1021/la063053o · Cited by 65
Self-citation
Cyclosporin A Aerosol Improves the Anticancer Effect of Paclitaxel Aerosol in Mice
Koshkina, N. V., Golunski, E., Roberts, L., Gilbert, B. E., & Knight, V. (2004) · Journal of Aerosol Medicine · doi:10.1089/089426804322994415 · Cited by 64
Aerosol Deposition of Lipid Complex Amphotericin-B (Abelcet) in Lung Transplant Recipients
Corcoran, T. E., Venkataramanan, R., Mihelc, K. M., Marcinkowski, A. L., Ou, J., McCook, B., Weber, L., Carey, M. E., Paterson, D. L., Pilewski, J. M., et al. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01529.x · Cited by 64
Inhalable liposomal formulation for vasoactive intestinal peptide
Hajos, F., Stark, B., Hensler, S., Prassl, R., & Mosgoeller, W. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.01.046 · Cited by 64
Novel vitamin E analogue and 9-nitro-camptothecin administered as liposome aerosols decrease syngeneic mouse mammary tumor burden and inhibit metastasis
Lawson, K. A., Anderson, K., Snyder, R. M., Simmons-Menchaca, M., Atkinson, J., Sun, L., Bandyopadhyay, A. M., Knight, V., Gilbert, B. E., Sanders, B. G., et al. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0817-y · Cited by 62
Development of Budesonide Microparticles Using Spray-Drying Technology for Pulmonary Administration: Design, Characterization, In Vitro Evaluation, and In Vivo Efficacy Study
Naikwade, S. R., Bajaj, A., Gurav, P. B., Gatne, M. M., & Soni, P. S. (2009) · AAPS PharmSciTech · doi:10.1208/s12249-009-9290-6 · Cited by 59
Development of cationic liposome formulations for intratracheal gene therapy of early lung cancer
Zou, Y., Zong, G., Ling, Y., & Perez-Soler, R. (2000) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700156 · Cited by 59
Proteases implicated in apoptosis: old and new
Moffitt, K. L., Martin, L., & Walker, B. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.62.05.0002 · Cited by 54
Liposome-based drug delivery to alveolar macrophages
Vyas, S. P., & Khatri, K. (2007) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.4.2.95 · Cited by 52
Liposomes for Drug Delivery to the Respiratory Tract
Taylor, K. M. G., & Fan, S. J. (1993) · Drug Development and Industrial Pharmacy · doi:10.3109/03639049309038764 · Cited by 52
A novel approach to the pulmonary delivery of liposomes in dry powder form to eliminate the deleterious effects of milling
Desai, T. R., Wong, J. P., Hancock, R. E. W., & Finlay, W. H. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10021 · Cited by 51
Development of Liposomal Amphotericin B Dry Powder Inhaler Formulation
Shah, S. P., & Misra, A. R. (2004) · Drug Delivery · doi:10.1080/10717540490467375 · Cited by 50
Comparison of Bilayer and Monolayer Properties of Phospholipid Systems Containing Dipalmitoylphosphatidylglycerol and Dipalmitoylphosphatidylinositol
Mansour, H. M., Wang, D.-S., Chen, C., & Zografi, G. (2001) · Langmuir · doi:10.1021/la0108454 · Cited by 49
Self-citation
Activity against rhinoviruses, toxicity, and delivery in aerosol of enviroxime in liposomes
Wyde, P. R., Six, H. R., Wilson, S. Z., Gilbert, B. E., & Knight, V. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.6.890 · Cited by 48
Aerosol delivery of liposomal all- trans -retinoic acid to the lungs
Parthasarathy, R. V., Gilbert, B. E., & Mehta, K. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050895 · Cited by 48
Formulations for Pulmonary Administration of Anticancer Agents to Treat Lung Malignancies
Carvalho, T. C., Carvalho, S. R., & McConville, J. T. (2011) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2009.0794 · Cited by 47
Aerosol Delivery of Liposomal Formulated Paclitaxel and Vitamin E Analog Reduces Murine Mammary Tumor Burden and Metastases
Latimer, P., Simmons-Menchaca, M., Snyder, R. M., Yu, W., Gilbert, B. E., Sanders, B. G., & Kline, K. A. (2009) · Experimental Biology and Medicine · doi:10.3181/0901-rm-8 · Cited by 47
The relationship between water vapor absorption and desorption by phospholipids and bilayer phase transitions
Mansour, H. M., & Zografi, G. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20810 · Cited by 44
Self-citation
Monitoring safety of liposomes containing rifampicin on respiratory cell lines andin vitroefficacy againstMycobacterium bovisin alveolar macrophages
Changsan, N., Nilkaeo, A., Pungrassami, P., & Srichana, T. (2009) · Journal of drug targeting · doi:10.3109/10611860903079462 · Cited by 42
Cyclosporin A liposome aerosol: Particle size and calculated respiratory deposition
Waldrep, J. C., Scherer, P. W., Keyhani, K., & Knight, V. (1993) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(93)90140-b · Cited by 42
Growth inhibition of established B16-F10 lung metastases by sequential aerosol delivery of p53 gene and 9-nitrocamptothecin
Gautam, A. K., Waldrep, J. C., Densmore, C. L., Koshkina, N. V., Melton, S., Roberts, L., Gilbert, B. E., & Knight, V. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301662 · Cited by 42
Evaluation of antitubercular drug‐loaded surfactants as inhalable drug‐delivery systems for pulmonary tuberculosis
Chimote, G., & Banerjee, R. (2009) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31959 · Cited by 41
Pulmonary Targeting of Nanoparticle Drug Matrices
Dandekar, P., Venkataraman, C., & Mehra, A. (2010) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2009.0784 · Cited by 39
Liposomal Aerosols in the Management of Pulmonary Infections
Gilbert, B. E. (1996) · Journal of Aerosol Medicine · doi:10.1089/jam.1996.9.111 · Cited by 38
Tolerability of prophylactic aerosolized liposomal amphotericin-B and impact on pulmonary function: Data from a randomized placebo-controlled trial
Slobbe, L., Boersma, E. H., & Rijnders, B. J. A. (2008) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2008.09.001 · Cited by 38
Delivery of rSLPI in a liposomal carrier for inhalation provides protection against cathepsin L degradation
Gibbons, A., McElvaney, N. G., Taggart, C. C., & Cryan, S. (2008) · Journal of Microencapsulation · doi:10.1080/02652040802466535 · Cited by 36
Pulmonary disposition of budesonide from liposomal dry prowder inhaler
Joshi, M., & Nisra, A. N. (2001) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2001.23.10.677118 · Cited by 36
A Dry Powder Formulation of Liposome-Encapsulated Recombinant Secretory Leukocyte Protease Inhibitor (rSLPI) for Inhalation: Preparation and Characterisation
Gibbons, A., McElvaney, N. G., & Cryan, S. (2010) · AAPS PharmSciTech · doi:10.1208/s12249-010-9500-2 · Cited by 35
Spray-Drying of liposomes for a Pulmonary Administration. I. Chemical Stability of Phospholipids
Goldbach, P., Brochart, H., & Stamm, A. (1993) · Drug Development and Industrial Pharmacy · doi:10.3109/03639049309047204 · Cited by 34
Nano-Liposomal Dry Powder Inhaler of Amiloride Hydrochloride
Chougule, M. B., Padhi, B. K., & Misra, A. R. (2006) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2006.405 · Cited by 34
Effect of Phospholipid Composition on Characterization of Liposomes Containing 9-Nitrocamptothecin
Chen, J., Ping, Q., Guo, J. X., Chu, X.-Z., & Song, M. (2006) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040500529077 · Cited by 32
Nanopharmaceuticals I: nanocarrier systems in drug delivery
Rhee, Y. S., & Mansour, H. M. (2010) · International Journal of Nanotechnology · doi:10.1504/ijnt.2011.037172 · Cited by 31
Self-citation
Possibilities of formoterol to enhance the peripheral lung deposition of the inhaled liposome corticosteroids
SAARI, S. M., Vidgren, M. T., Herrala, J., Turjanmaa, V., Koskinen, M. O., & Nieminen, M. M. (2002) · Respiratory Medicine · doi:10.1053/rmed.2002.1393 · Cited by 29
Formulation Challenges of Powders for the Delivery of Small Molecular Weight Molecules as Aerosols
Hickey, A. J. (2002) · CRC Press eBooks · doi:10.1201/9780203910337-73 · Cited by 29
Disposition kinetics of ketotifen from liposomal dry powder for inhalation in rat lung
Joshi, M., & Misra, A. R. (2003) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2003.03813.x · Cited by 28
Lipids in Nanotechnology
(2012) · Elsevier eBooks · doi:10.1016/c2015-0-02410-8 · Cited by 28
Chitosan-coated antifungal formulations for nebulisation
Albasarah, Y. Y., Somavarapu, S., Stapleton, P. D., & Taylor, K. M. G. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.62.07.0002 · Cited by 28
The deposition and clearance of liposome entrapped 99mTc-DTPA in the human respiratory tract
Barker, S. A., Taylor, K. M. G., & Short, M. D. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)90051-5 · Cited by 27
Development of Liposomal Salbutamol Sulfate Dry Powder Inhaler Formulation
Huang, W., Yang, Z., Wu, H., Wong, Y.-F., Zhao, Z., & Liu, L. (2010) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.33.512 · Cited by 26
Experimental pulmonary delivery of cyclosporin A by liposome aerosol
Waldrep, J. C., Arppe, J., Jansa, K., & Vidgren, M. T. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00322-0 · Cited by 25
CHARACTERIZATION AND ADMINISTRATION OF CYCLOSPORINE LIPOSOMES AS A SMALL-PARTICLE AEROSOL
Gilbert, B. E., Wilson, S. Z., Garçon, N., Wyde, P. R., & Knight, V. (1993) · Transplantation · doi:10.1097/00007890-199310000-00037 · Cited by 24
Efficacy of Combination Antifungal Therapy with Intraperitoneally Administered Micafungin and Aerosolized Liposomal Amphotericin B against Murine Invasive Pulmonary Aspergillosis
Takazono, T., Izumikawa, K., Mihara, T., Kosai, K., Saijo, T., Imamura, Y., Miyazaki, T., Seki, M., Kakeya, H., Yamamoto, Y., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00285-09 · Cited by 23
Nanopharmaceuticals II: application of nanoparticles and nanocarrier systems in pharmaceutics and nanomedicine
Wu, X. Y., & Mansour, H. M. (2010) · International Journal of Nanotechnology · doi:10.1504/ijnt.2011.037173 · Cited by 23
Self-citation
Spray-Drying of Liposomes for a Pulmonary Administration. II. Retention of Encapsulated Materials
Goldbach, P., Brochart, H., & Stamm, A. (1993) · Drug Development and Industrial Pharmacy · doi:10.3109/03639049309047205 · Cited by 21
High dose cyclosporin A and budesonide-liposome aerosols.
Waldrep, J. C., Arppe, J., Jansa, K., & Knight, V. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)04912-0 · Cited by 21
Budesonide/formoterol combination in COPD: a US perspective
Sharafkhaneh, A. (2010) · International Journal of COPD · doi:10.2147/copd.s4215 · Cited by 21
Formulation Challenges of Powders for the Delivery of Small Molecular Weight Molecules as Aerosols
Hickey, A. J., & Mansour, H. M. (2008) · CRC Press eBooks · doi:10.3109/9781420045260-44 · Cited by 21
Self-citation
Characterization of the In Situ Structural and Interfacial Properties of the Cationic Hydrophobic Heteropolypeptide, KL4, in Lung Surfactant Bilayer and Monolayer Models at the Air−Water Interface: Implications for Pulmonary Surfactant Delivery
Mansour, H. M., Damodaran, S., & Zografi, G. (2008) · Molecular Pharmaceutics · doi:10.1021/mp700123p · Cited by 17
Self-citation
LIPID NANOPARTICULATE DRUG DELIVERY AND NANOMEDICINE
Mansour, H. M., Rhee, Y.-S., Park, C., & DeLuca, P. P. (2012) · Elsevier eBooks · doi:10.1016/b978-0-9818936-7-9.50012-3 · Cited by 17
Self-citation
Differential Behaviour of Fluid Liposomes Toward Mammalian Epithelial Cells and Bacteria: Restriction of Fusion to Bacteria
Desjardins, A., Chen, T., Khalil, H., Sayasith, K., & Lagacé, J. (2002) · Journal of drug targeting · doi:10.1080/10611860290007522 · Cited by 16
An alternative aerosol delivery system for amiloride.
Everard, M. L., Devadason, S. G., Sunderland, V. B., & Souëf, P. N. L. (1995) · Thorax · doi:10.1136/thx.50.5.517 · Cited by 15
Liposomes as a Carrier for Pulmonary Delivery of Peptides and Proteins
Bi, R., & Zhang, N. (2007) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2007.050 · Cited by 15
Nebulized Liposomal Amphotericin B and Combined Systemic Antifungal Therapy for the Treatment of Severe Pulmonary Aspergillosis after Allogeneic Hematopoietic Stem Cell Transplant for a Fatal Mitochondrial Disorder
Castagnola, E., Moresco, L., Cappelli, B., Cuzzubbo, D., Moroni, C., Lanino, E., & Faraci, M. (2007) · Journal of Chemotherapy · doi:10.1179/joc.2007.19.3.339 · Cited by 13
Pulmonary inhalation aerosols for targeted antibiotics drug delivery
Park, C., Mansour, H. M., & Hayes, D. (2011) · Cited by 13
Self-citation
Cyclosporin A enhances paclitaxel toxicity against leukemia and respiratory epithelial cancers.
Ross, H. J., Canada, A. L., & Slater, L. M. (1997) · PubMed · Cited by 12
Comprar Drug Information Handbook with International Brand Names Index | Charles F. Lacy | 9781591952312 | Lexi-Comp Inc
Lacy, C. F., Armstrong, L. L., Goldman, M., & Lance, L. L. (2008) · Cited by 10
Lipids in nanotechnology
Ahmad, M. (2012) · Cited by 6

Research works printed but not linked: 4

Hickey AJ, Mansour HM (2009) Chapter 5: delivery of drugs by the pulmonary route. In: Florence AT, Siepmann J (eds) Modern pharmaceutics, vol 2, 5th edn. Taylor and Francis, New York, pp 191–219
Perrie Y, Rades T (2010) Pharmaceutics—drug delivery and targeting. Pharmaceutical Press, London
Darwis Y, Kellaway IW (2002) The lyophilisation and aerosolisation of liposomes for pulmonary drug administration. STP Pharma Sci 12(2):91–96
DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM (2008) Pharmacotherapy: a pathophysiological approach, 7th edn. McGraw-Hill Medical, New York

Sorted by citations

Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles
Singh, A. P., Biswas, A., Shukla, A., & Maiti, P. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0068-3 · Cited by 645
Nanoparticle-Mediated Pulmonary Drug Delivery: A Review
Paranjpe, M., & Müller-Goymann, C. C. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15045852 · Cited by 467
Delivery strategies for sustained drug release in the lungs
Loira-Pastoriza, C., Todoroff, J., & Rita Vanbever, A. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.017 · Cited by 395
Nanotechnology approaches for inhalation treatment of lung diseases
Kuzmov, A., & Minko, T. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.07.024 · Cited by 356
Technological and practical challenges of dry powder inhalers and formulations
Hoppentocht, M., Hagedoorn, P., Frijlink, H. W., & de Boer, A. H. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.04.004 · Cited by 304

See all 148

Authors: Willis, L., Hayes, D., & Mansour, H. M.
Affiliations: University of Kentucky (US)
Nationwide Children's Hospital (US)
Corresponding author: Mansour, Heidi M.
ORCID: Hayes, Don
Mansour, Heidi M.
Venue: Lung
Publisher: Springer Science and Business Media LLC
Published: 2012-01-25
Volume: 190
Issue: 3
Pages: 251-262
ISSN: 0341-2040 (ISSN-L)
1432-1750
DOI: 10.1007/s00408-011-9360-x
OpenAlex: W2081617033
Cited by: 148
References: 117
Citations by year: 2026: 8 · 2025: 10 · 2024: 10 · 2023: 12 · 2022: 11 · 2021: 7 · 2020: 14 · 2019: 8 · 2018: 8 · 2017: 9 · 2016: 8 · 2015: 8 · 2014: 22 · 2013: 11 · 2012: 2
FWCI: 2.32
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Lung (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Keywords: lipospheres, proliposomes, dry powder inhaler, phospholipids, pulmonary surfactant, controlled drug release, formulation stability, lung disease, lung cancer, tuberculosis, cystic fibrosis, chronic obstructive pulmonary disease, asthma, pulmonary infection
MeSH terms: Administration, Inhalation, Aerosols, Pharmaceutical Preparations, Humans, Liposomes, Lung, Lung Diseases, Powders, Nanocapsules

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Therapeutic Liposomal Dry Powder Inhalation Aerosols for Targeted Lung Delivery

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks